Clinical Trial to Evaluate Safety and Tolerability of OratecanTM in Patients With Advanced Solid Malignancies (Oratecan-102)

Clinical trial NCT00986843 · COMPLETED

Trial details

NCT number: NCT00986843
Sponsor: Hanmi Pharmaceutical Company Limited
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Malignancies

Start date: 2008-06-01
Primary completion: 2010-02-01
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.